-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Twist Bioscience with Neutral Rating, Announces Price Target of $144

Benzinga·09/09/2026 13:26:25
Listen to the news
UBS analyst Doug Schenkel initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Neutral rating and announces Price Target of $144.